Cargando…
Human T lymphocytes at tumor sites
CD4(+) and CD8(+) T lymphocytes mediate most of the adaptive immune response against tumors. Naïve T lymphocytes specific for tumor antigens are primed in lymph nodes by dendritic cells. Upon activation, antigen-specific T cells proliferate and differentiate into effector cells that migrate out of p...
Autores principales: | Notarbartolo, Samuele, Abrignani, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668216/ https://www.ncbi.nlm.nih.gov/pubmed/36385379 http://dx.doi.org/10.1007/s00281-022-00970-4 |
Ejemplares similares
-
Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation
por: Panzeri, Ilaria, et al.
Publicado: (2015) -
Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease
por: de Candia, Paola, et al.
Publicado: (2014) -
De novo transcriptome profiling of highly purified human lymphocytes primary cells
por: Bonnal, Raoul J.P., et al.
Publicado: (2015) -
CD1d-restricted Help To B Cells By Human Invariant Natural Killer T Lymphocytes
por: Galli, Grazia, et al.
Publicado: (2003) -
The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T(H)17 lineage in humans
por: Mitsdoerffer, Meike, et al.
Publicado: (2022)